Prevalence of chronic kidney disease in two major Indian cities and projections for associated cardiovascular disease

Kidney International

Volumn 88, Issue 1, 2015, Pages 178-185

  Anand, Shuchi ^a,b,c   Shivashankar, Roopa ^a,b   Ali, Mohammed K ^d   Kondal, Dimple ^a,b   Binukumar, B ^a,b   Montez Rath, Maria E ^c   Ajay, Vamadevan S ^a,b   Pradeepa, R ^e   Deepa, M ^e   Gupta, Ruby ^a,b   Mohan, Viswanathan ^e   Narayan, K M Venkat ^d   Tandon, Nikhil ^f   Chertow, Glenn M ^c   Prabhakaran, Dorairaj ^a,b  

^a PUBLIC HEALTH FOUNDATION OF INDIA   (India)

^b Centre for chronic disease control (CoE CARRS)   (India)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d EMORY UNIVERSITY   (United States)

^e MADRAS DIABETES RESEARCH FOUNDATION   (India)

^f ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Albuminuria; Cardiovascular disease; Chronic kidney disease; Epidemiology; Resource poor settings; South Asians

Indexed keywords

CREATININE; HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; AGE DISTRIBUTION; AGED; ALBUMINURIA; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; FRAMINGHAM AND INTERHEART MODIFIABLE RISK SCORE; HEALTH SURVEY; HIGH RISK PATIENT; HUMAN; INDIA; INDIAN; KIDNEY DISEASE IMPROVING GLOBAL OUTCOME; MAJOR CLINICAL STUDY; MALE; POPULATION DISTRIBUTION; POPULATION RESEARCH; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; SCORING SYSTEM; SEX DIFFERENCE; AGE; CARDIOVASCULAR DISEASES; COMPLICATION; METABOLISM; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA; URBAN POPULATION; YOUNG ADULT;

ADULT; AGE FACTORS; AGED; ALBUMINURIA; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INDIA; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; SEX FACTORS; URBAN POPULATION; YOUNG ADULT;

EID: 84934435590     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2015.58     Document Type: Article

References (44)

1. Prentice AM. The emerging epidemic of obesity in developing countries. Int J Epidemiol 2006; 35: 93-99.
2. Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world-a growing challenge. N Engl J Med 2007; 356: 213-215.
3. Barsoum RS. Chronic kidney disease in the developing world. N Engl J Med 2006; 354: 997-999.
4. Chronic Kidney Disease Prognosis Consortium, Matsushita C, van der Velde K, Astor M et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375: 2073-2081.
5. USRDS 2013. Atlas of End-Stage Renal Disease [Internet]. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda 2013 (cited 7 January 2013).
6. Ramachandran A, Snehalatha C, Kapur A et al. High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia 2001; 44: 1094-1101.
7. Yusuf S, Reddy S, Ounpuu S et al. Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 2001; 104: 2855-2864.
8. Agarwal SK, Dash SC, Irshad M et al. Prevalence of chronic renal failure in adults in Delhi, India. Nephrol Dial Transplant 2005; 20: 1638-1642.
9. Singh AK, Farag YM, Mittal BV et al. Epidemiology and risk factors of chronic kidney disease in India-results from the SEEK (Screening and Early Evaluation of Kidney Disease) study. BMC Nephrol 2013; 14: 114.
10. Singh NP, Ingle GK, Saini VK et al. Prevalence of low glomerular filtration rate, proteinuria and associated risk factors in North India using Cockcroft-Gault and Modification of Diet in Renal Disease equation: an observational, cross-sectional study. BMC Nephrol 2009; 10: 4.
11. Kidney Disease: Improving Global Outcomes Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl [Internet] 2013;:1-150 pp.
12. D'Agostino RB Sr, Vasan RS, Pencina MJ et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008; 117: 743-753.
13. McGorrian C, Yusuf S, Islam S et al. Estimating modifiable coronary heart disease risk in multiple regions of the world: the INTERHEART Modifiable Risk Score. Eur Heart J 2011; 32: 581-589.
14. Inker LA, Schmid CH, Tighiouart H et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 2012; 367: 20-29.
15. Coresh J, Selvin E, Stevens LA et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047.
16. Otero A, de Francisco A, Gayoso P et al. Prevalence of chronic renal disease in Spain: results of the EPIRCE study. Nefrologia 2010; 30: 78-86.
17. Imai E, Horio M, Watanabe T et al. Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol 2009; 13: 621-630.
18. Hallan SI, Coresh J, Astor BC et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol 2006; 17: 2275-2284.
19. Zhang L, Wang F, Wang L et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 2012; 379: 815-822.
20. World DataBank: Health Nutrition and Population Statistics [Internet]. The World Bank. 2010 (cited June 2013).
21. Glassock RJ, Winearls C. Screening for CKD with eGFR: doubts and dangers. Clin J Am Soc Nephrol 2008; 3: 1563-1568.
22. Nelson RG, Kunzelman CL, Pettitt DJ et al. Albuminuria in type 2 (noninsulin-dependent) diabetes mellitus and impaired glucose tolerance in Pima Indians. Diabetologia 1989; 32: 870-876.
23. Appel LJ, Wright JT Jr, Greene T et al. Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med 2010; 363: 918-929.
24. Levey AS, Coresh J. Chronic kidney disease. Lancet 2012; 379: 165-180.
25. de Boer IH, Rue TC, Cleary PA et al. Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort. Arch Intern Med 2011; 171: 412-420.
26. Parving HH, Lehnert H, Brochner-Mortensen J et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001; 345: 870-878.
27. Gaede P, Lund-Andersen H, Parving HH et al. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008; 358: 580-591.
28. Unnikrishnan RI, Rema M, Pradeepa R et al. Prevalence and risk factors of diabetic nephropathy in an urban South Indian population: the Chennai Urban Rural Epidemiology Study (CURES 45). Diabetes Care 2007; 30: 2019-2024.
29. Chugh KS. Five decades of Indian nephrology: a personal journey. Am J Kidney Dis 2009; 54: 753-763.
30. Khanna U. The economics of dialysis in India. Indian J Nephrol 2009; 19: 1-4.
31. Teo BW, Xu H, Wang D et al. GFR estimating equations in a multiethnic Asian population. Am J Kidney Dis 2011; 58: 56-63.
32. Chow CK, Joshi R, Celermajer DS et al. Recalibration of a Framingham risk equation for a rural population in India. J Epidemiol Commun Health 2009; 63: 379-385.
33. Nair M, Ali MK, Ajay VS et al. CARRS Surveillance study: design and methods to assess burdens from multiple perspectives. BMC Public Health 2012; 12: 701.
34. National Family Health Survey, India [Internet]. International Institute for Population Sciences, 2009 (cited March 2014).
35. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157-163.
36. National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-3421.
37. Browning LM, Hsieh SD, Ashwell M. A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0. 5 could be a suitable global boundary value. Nutr Res Rev 2010; 23: 247-269.
38. World Health Organization. Waist Circumference and Waist-Hip Ratio: Report of a WHO Expert Consultation. World Health Organization: Geneva, 2008.
39. James PA, Oparil S, Carter BL et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014; 311: 507-520.
40. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33: S62-S69.
41. Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612.
42. Shlipak MG, Matsushita K, Arnlov J et al. Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med 2013; 369: 932-943.
43. Yusuf S, Rangarajan S, Teo K et al. Cardiovascular risk and events in 17 low-, middle-, and high-income countries. N Engl J Med 2014; 371: 818-827.
44. Micallef L, Rodgers P. eulerAPE: Drawing Area-proportional 3-Venn Diagrams Using Ellipses. PLoS One 9: e101717.